Preliminary reports point out conolidine could inhibit specific ion channels, cutting down neuronal excitability and restricting discomfort signals. This mechanism is particularly suitable in neuropathic ache, where abnormal signaling leads to persistent soreness. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to ache https://hugha951ume9.blogpixi.com/profile